Fingerprint
Dive into the research topics of 'Comparative safety and effectiveness of vedolizumab to tumour necrosis factor antagonist therapy for Crohn's disease'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Comparative safety and effectiveness of vedolizumab to tumour necrosis factor antagonist therapy for Crohn's disease
the VICTORY Collaboration
Research output: Contribution to journal › Article › peer-review
42
Scopus
citations